Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 18,999 |
|
|||||
| News | - | ||||||
| Day High | 2.34 | Low High |
|||||
| Day Low | 2.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| VYNE Therapeutics Inc | VYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -2.17% | 2.25 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.26 | 2.25 | 2.34 | 2.25 | 2.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 150 | 18,999 | $ 2.29 | $ 43,449 | - | 1.67 - 8.81 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 672 | $ 2.25 | USD |
VYNE Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 31.86M | 14.10M | - | 424k | -28.45M | -2.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
VYNE Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.93 | 2.93 | 2.25 | 2.52 | 32,482 | -0.68 | -23.21% |
| 1 Month | 2.33 | 3.17 | 2.1986 | 2.74 | 172,136 | -0.08 | -3.43% |
| 3 Months | 1.80 | 3.17 | 1.67 | 2.44 | 108,208 | 0.45 | 25.00% |
| 6 Months | 2.70 | 4.4808 | 1.67 | 2.69 | 262,609 | -0.45 | -16.67% |
| 1 Year | 3.35 | 8.81 | 1.67 | 3.80 | 315,013 | -1.10 | -32.84% |
| 3 Years | 95.40 | 98.46 | 1.67 | 20.08 | 720,570 | -93.15 | -97.64% |
| 5 Years | 106.56 | 237.60 | 1.67 | 96.05 | 1,257,262 | -104.31 | -97.89% |
VYNE Therapeutics Description
| VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. |
